Published in Dig Liver Dis on September 13, 2005
Positive role of CCAAT/enhancer-binding protein homologous protein, a transcription factor involved in the endoplasmic reticulum stress response in the development of colitis. Am J Pathol (2009) 1.32
Immunopathogenesis of inflammatory bowel disease. World J Gastroenterol (2008) 1.28
Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades. Am J Pathol (2008) 1.18
Posttranslationally modified proteins as mediators of sustained intestinal inflammation. Am J Pathol (2006) 1.13
Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent. Inflamm Bowel Dis (2008) 0.89
Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease. Expert Rev Clin Immunol (2010) 0.85
Black tea polyphenol theaflavin suppresses LPS-induced ICAM-1 and VCAM-1 expression via blockage of NF-κB and JNK activation in intestinal epithelial cells. Inflamm Res (2010) 0.82
Bilirubin prevents acute DSS-induced colitis by inhibiting leukocyte infiltration and suppressing upregulation of inducible nitric oxide synthase. Am J Physiol Gastrointest Liver Physiol (2015) 0.81
Lancemaside A from Codonopsis lanceolata modulates the inflammatory responses mediated by monocytes and macrophages. Mediators Inflamm (2014) 0.80
Endothelial dysfunction in inflammatory bowel diseases: Pathogenesis, assessment and implications. World J Gastroenterol (2016) 0.80
Orally administered liposomal formulations for colon targeted drug delivery. Front Pharmacol (2014) 0.76
The clinical potential of etrolizumab in ulcerative colitis: hypes and hopes. Therap Adv Gastroenterol (2016) 0.75
Alemtuzumab and natalizumab: the monoclonal antibody story continues. Can J Infect Dis Med Microbiol (2006) 0.75
Systematic review: Sprue-like enteropathy associated with olmesartan. Aliment Pharmacol Ther (2014) 2.81
Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation (1998) 2.75
Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol (2001) 2.53
Aneurysmal bone cyst of the mobile spine: report on 41 cases. Spine (Phila Pa 1976) (2001) 2.37
Tick-borne virus diseases of human interest in Europe. Clin Microbiol Infect (2004) 2.30
Complications of double balloon enteroscopy: a multicenter survey. Endoscopy (2007) 2.28
Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet (1998) 2.15
Osteoid osteoma. Direct visual identification and intralesional excision of the nidus with minimal removal of bone. J Bone Joint Surg Br (1999) 2.13
A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery. J Crohns Colitis (2012) 2.12
Atrophic gastritis as a cause of hyperhomocysteinaemia. Aliment Pharmacol Ther (2004) 2.09
Direct genetic detection of Dobrava virus in Greek and Albanian patients with hemorrhagic fever with renal syndrome. J Infect Dis (1996) 1.99
Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther (2005) 1.78
Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis. Gastroenterology (1999) 1.78
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther (2006) 1.76
Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther (2002) 1.73
Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability. Circulation (2001) 1.72
Regulation of apoptosis by PML and the PML-NBs. Oncogene (2008) 1.67
Body composition changes induced by chronic ethanol abuse: evaluation by dual energy X-ray absorptiometry. Am J Gastroenterol (2000) 1.63
Abdominal CT findings may suggest coeliac disease. Dig Liver Dis (2005) 1.63
Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria. Dig Dis Sci (1998) 1.61
Caudal blockade as alternative therapeutic approach in neonatal arterial thrombosis. Eur J Pediatr (2001) 1.61
Prevalence and early diagnosis of coeliac disease in autoimmune thyroid disorders. Ital J Gastroenterol Hepatol (1999) 1.60
Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) plasma levels in inflammatory bowel diseases. Am J Gastroenterol (2004) 1.59
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial. Aliment Pharmacol Ther (2003) 1.59
West Nile virus in Europe: emergence, epidemiology, diagnosis, treatment, and prevention. Clin Microbiol Infect (2013) 1.58
Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut (2003) 1.56
Intraepithelial dendritic cells and selective activation of Th2-like lymphocytes in patients with atopic asthma. Chest (1993) 1.55
Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther (2005) 1.54
NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment Pharmacol Ther (2003) 1.54
Push-and-pull enteroscopy in the small bowel using the double-balloon technique: results of a prospective European multicenter study. Endoscopy (2005) 1.53
The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther (2001) 1.52
Epithelial-cell apoptosis and proliferation in Helicobacter pylori-related chronic gastritis. Ital J Gastroenterol Hepatol (1998) 1.50
Cirrhotic cardiomyopathy. Dig Liver Dis (2007) 1.49
A five-year perspective on the situation of haemorrhagic fever with renal syndrome and status of the hantavirus reservoirs in Europe, 2005-2010. Euro Surveill (2011) 1.45
Minimally invasive percutaneous fixation in the treatment of thoracic and lumbar spine fractures. Eur Spine J (2009) 1.45
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig Liver Dis (2010) 1.45
Portal vein thrombosis in patients undergoing orthotopic liver transplantation: intraoperative endovascular radiological procedures. Transplant Proc (2005) 1.45
Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa. Dig Liver Dis (2005) 1.39
Bacteroides thetaiotaomicron in the gut: molecular aspects of their interaction. Dig Liver Dis (2007) 1.36
Is obesity protective for osteoporosis? Evaluation of bone mineral density in individuals with high body mass index. Int J Clin Pract (2010) 1.36
Human intestinal lamina propria lymphocytes are naturally permissive to HIV-1 infection. Eur J Immunol (1999) 1.35
Clinical features, diagnostic and therapeutic approaches to haematogenous vertebral osteomyelitis. Eur Rev Med Pharmacol Sci (2005) 1.29
Large-scale spatial distribution of virioplankton in the Adriatic Sea: testing the trophic state control hypothesis. Appl Environ Microbiol (2003) 1.28
Ongoing outbreak of West Nile virus infection in humans, Greece, July to August 2011. Euro Surveill (2011) 1.24
Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection. Aliment Pharmacol Ther (2000) 1.24
Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries. J Virol (2001) 1.19
Liver transplantation: the Italian experience. Dig Liver Dis (2002) 1.19
Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome. Aliment Pharmacol Ther (2005) 1.19
Review article: breath testing for human liver function assessment. Aliment Pharmacol Ther (2002) 1.19
Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. Aliment Pharmacol Ther (2007) 1.18
Increased expression of endothelin in bronchial epithelial cells of asthmatic patients and effect of corticosteroids. Am Rev Respir Dis (1992) 1.18
High dosage rifaximin for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther (2007) 1.17
Predictive factors for local recurrence in osteosarcoma: 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy. Acta Orthop Scand (1998) 1.16
A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther (2000) 1.16
Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy. Ann Oncol (1997) 1.16
Helicobacter pylori eradication helps resolve pyloric and duodenal stenosis. J Clin Gastroenterol (1996) 1.16
High prevalence of Helicobacter pylori type I virulent strains in patients with systemic sclerosis. J Rheumatol (2000) 1.15
Fatty liver and drugs. Eur Rev Med Pharmacol Sci (2005) 1.15
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther (2015) 1.15
Eotaxin expression and eosinophilic inflammation in asthma. Biochem Biophys Res Commun (1997) 1.14
Modular endoprosthetic replacement after total resection of the femur for malignant tumour. Int Orthop (1994) 1.14
Bronchial epithelial cells of patients with asthma release chemoattractant factors for T lymphocytes. J Allergy Clin Immunol (1993) 1.14
High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection. Aliment Pharmacol Ther (2004) 1.14
Intraepiphyseal resection of the proximal tibia and its impact on lower limb growth. Clin Orthop Relat Res (1999) 1.13
A silenced allele in the Colton blood group system. Vox Sang (2010) 1.13
Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration. Diabetes (2000) 1.12
Helicobacter pylori infection and diabetes. Minerva Med (2010) 1.11
Abnormal vascular network complexity: a new phenotypic marker in hereditary non-polyposis colorectal cancer syndrome. Gut (2003) 1.11
Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation. Clin Exp Immunol (1998) 1.11
Symptomatic vertebral hemangioma: the treatment of 23 cases and a review of the literature. Chir Organi Mov (2002) 1.11
Levels of endothelin in the bronchoalveolar lavage fluid of patients with symptomatic asthma and reversible airflow obstruction. J Allergy Clin Immunol (1991) 1.10
White cell apoptosis in platelet concentrates. Transfusion (2000) 1.09
The allergen Der p1 induces NF-kappaB activation through interference with IkappaB alpha function in asthmatic bronchial epithelial cells. Biochem Biophys Res Commun (1997) 1.09
Sandfly-fever outbreak in Cyprus: are phleboviruses still a health problem? Travel Med Infect Dis (2007) 1.09
Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe. Euro Surveill (2005) 1.08
Osteosarcoma of the bones of the foot--an easily misdiagnosed malignant tumor. Mayo Clin Proc (1998) 1.08
Letter: Faecal microbiota transplantation--not a one-size-fits-all approach. Aliment Pharmacol Ther (2014) 1.07
Staging and treatment of osteoblastoma in the mobile spine: a review of 51 cases. Eur Spine J (2012) 1.07
Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer. J Clin Oncol (1994) 1.06
Age-related expansion of functionally inefficient cells with markers of natural killer activity in Down's syndrome. Blood (1991) 1.06
The Italian experience on paediatric liver transplantation: 1988-1999 report. Dig Liver Dis (2002) 1.06
Importance of changes in epithelial cell turnover during Helicobacter pylori infection in gastric carcinogenesis. Gut (1998) 1.06
Relative lymphocyte count: a prognostic indicator of mortality in elderly patients with congestive heart failure. Am Heart J (2001) 1.05
Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Aliment Pharmacol Ther (2004) 1.04
Retracted Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2003) 1.03
Extradigestive manifestations of Helicobacter pylori gastric infection. Gut (1999) 1.03
Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole. Eur Rev Med Pharmacol Sci (2009) 1.03
Increased carotid intima-media thickness in patients with inflammatory bowel disease. Aliment Pharmacol Ther (2005) 1.02
Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication. Dig Liver Dis (2008) 1.01